{
    "id": 25703,
    "fullName": "DDX3X over exp",
    "impact": "none",
    "proteinEffect": "no effect",
    "geneVariantDescriptions": [
        {
            "description": "DDX3X over exp indicates an over expression of the Ddx3x protein and/or mRNA. However, the mechanism causing the over expression is unspecified.",
            "references": [
                {
                    "id": 275,
                    "pubMedId": null,
                    "title": "External Reference Not Available (N/A)",
                    "url": "https://ckb.jax.org/about/glossaryOfTerms"
                }
            ]
        }
    ],
    "type": "non-specific",
    "gene": {
        "id": 1654,
        "geneSymbol": "DDX3X",
        "terms": [
            "DDX3X",
            "CAP-Rf",
            "DBX",
            "DDX14",
            "DDX3",
            "HLP2",
            "MRX102"
        ]
    },
    "variant": "over exp",
    "createDate": "11/01/2016",
    "updateDate": "04/16/2018",
    "referenceTranscriptCoordinates": null,
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 9101,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, treatment with RK-33 decreased viability and induced cell-cycle arrest in prostate cancer cell lines expressing high levels of DDX3X in culture (PMID: 27634756).",
            "molecularProfile": {
                "id": 26735,
                "profileName": "DDX3X over exp"
            },
            "therapy": {
                "id": 4898,
                "therapyName": "RK-33",
                "synonyms": null
            },
            "indication": {
                "id": 10283,
                "name": "prostate cancer",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 6908,
                    "pubMedId": 27634756,
                    "title": "RK-33 Radiosensitizes Prostate Cancer Cells by Blocking the RNA Helicase DDX3.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/27634756"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 9102,
            "approvalStatus": "Preclinical - Cell line xenograft",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, RK-33 in combination with radiotherapy worked synergistically to inhibit proliferation and reduce DNA damage response in DDX3X-over expressing prostate cancer cell lines, and to inhibited tumor growth in DDX3X-over expressing prostate cancer cell lines (PMID: 27634756).",
            "molecularProfile": {
                "id": 26735,
                "profileName": "DDX3X over exp"
            },
            "therapy": {
                "id": 4899,
                "therapyName": "Radiotherapy + RK-33",
                "synonyms": null
            },
            "indication": {
                "id": 10283,
                "name": "prostate cancer",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 6908,
                    "pubMedId": 27634756,
                    "title": "RK-33 Radiosensitizes Prostate Cancer Cells by Blocking the RNA Helicase DDX3.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/27634756"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 26735,
            "profileName": "DDX3X over exp",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        
    ]
}